IL-2 Can Signal Via Chemokine Receptors to Promote Regulatory T Cells' Suppressive Function.

Hao Sun,Ho-Sup Lee,Sarah Hyun-Ji Kim,Mikhael Fernandes de Lima,Alexandre R. Gingras,Qinyi Du,Wilma McLaughlin,Jailail Ablack,Miguel A. Lopez-Ramirez,Frederic Lagarrigue,Zhichao Fan,John T. Chang,Derek VanDyke,Jamie B. Spangler,Mark H. Ginsberg
DOI: https://doi.org/10.1016/j.celrep.2023.112996
IF: 8.8
2023-01-01
Cell Reports
Abstract:Canonical interleukin-2 (IL-2) signaling via the high-affinity CD25-containing IL-2 receptor-Janus kinase (JAK) 1,3-signal transducer and activator of transcription 5 (STAT5) pathway is essential for development and main-tenance of CD4+CD25HiFoxp3+ regulatory T cells (Tregs) that support immune homeostasis. Here, we report that IL-2 signaling via an alternative CD25-chemokine receptor pathway promotes the suppressive function of Tregs. Using an antibody against CD25 that biases IL-2 signaling toward this alternative pathway, we establish that this pathway increases the suppressive activity of Tregs and ameliorates murine experimental autoimmune encephalomyelitis (EAE). Furthermore, heparan sulfate, an IL-2-binding element of cell surfaces and extracellular matrix, or an engineered IL-2 immunocytokine can also direct IL-2 signaling toward this alternative pathway. Overall, these data reveal a non-canonical mechanism for IL-2 signaling that promotes suppressive functions of Tregs, further elucidates how IL-2 supports immune homeostasis, and suggests approaches to promote or suppress Treg functions.
What problem does this paper attempt to address?